CELH241213C17000
- 14.00
- 0.000.00%
Celsius Holdings Newsroom
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Costco, Broadcom, Celsius Holdings, Meta Platforms, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Celsius Holdings Options Spot-On: On December 12th, 183.16K Contracts Were Traded, With 676.9K Open Interest
On December 12th ET, $Celsius Holdings(CELH.US)$ had active options trading, with a total trading volume of 183.16K options for the day, of which put options accounted for 14.82% of the total
Unusual Options Activity: BABA, CMA and Others Attract Market Bets, BABA V/OI Ratio Reaches 764.7
EST Dec 12th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Spotlight on Celsius Holdings: Analyzing the Surge in Options Activity
Celsius' 'Better-For-You' Edge Could Unlock Equity Upside, Says JP Morgan Analyst
Why Are Celsius (CELH) Shares Soaring Today
Soft Drink Makers, Celsius Holdings, General Mills: Trending Tickers
Non-alcoholic Beverages Set to Benefit in 2025 From Impulse Buying, Convenience Store Traffic - Analyst
Stocks Making the Biggest Moves Premarket: Uber, Celsius Holdings, Adobe, Chewy and More
J.P. Morgan Initiates Celsius Holdings(CELH.US) With Buy Rating, Announces Target Price $37
Deutsche Bank Initiates Celsius Holdings(CELH.US) With Hold Rating, Announces Target Price $32
Best Stock to Buy Right Now: Celsius Vs. Coca-Cola
Deutsche Bank Initiates Coverage On Celsius Holdings With Hold Rating, Announces Price Target of $32
Express News | Celsius Holdings Inc : JP Morgan Initiates Coverage With Overweight Rating; Price Target $37
Red Bull May Have Won the 2024 Energy Drink Battle as It Fended off Celsius and Monster
Celsius Holdings Inc. (CELH) Is Attracting Investor Attention: Here Is What You Should Know
Celcuity Announced Overall Survival Data From Two Patient Cohorts Evaluated In A Phase 1B Trial With Gedatolisib, A PI3K/mTORC1/2 Inhibitor, In Combination With Palbociclib And Either Letrozole Or Fulvestrant, In Patients With HR+, HER2-advanced Or...
BofA Securities Maintains Celsius Holdings(CELH.US) With Sell Rating, Maintains Target Price $26
Analysts Offer Insights on Consumer Goods Companies: Constellation Brands (STZ) and Celsius Holdings (CELH)